Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/23/2003US20030199080 Devices for the electrochemical detection of a nucleotide sequence, analysis cassettes, systems of analysis cassettes, supplemental modules, and methods for producing analysis cassettes
10/23/2003US20030199079 Matrix material is impregnated with boric acid buffer with a pH which is larger or equal to 10.5 or with a copper or nickel salt for stabilizing the content of glycated protein of a sample on such matrix
10/23/2003US20030199078 Lysing a biological sample containing an analyte in a reaction vessel, adding a solid adsorption matrix, incubating to bind analyte to the adsorption matrix, removing non-bound components, incubating to elute analyte from the matrix
10/23/2003US20030199070 Crystallization of ribosome recycling factor (RRF) and method of developing inhibitor of RRF
10/23/2003US20030199065 Coating a solution composed of a solvent and a non-ionic surfactant having hydrophilic-lipophilic balance number < 5 on surface, drying the surface to remove solvent and thereby bring surfactant into direct contact with hydrophobic polymer
10/23/2003US20030199064 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199063 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199062 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199061 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199059 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199058 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199057 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199056 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199052 PRO polypeptides; fused to heterologous polypeptide sequences
10/23/2003US20030199051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199044 IL-17 homologous polypeptides and therapeutic uses thereof
10/23/2003US20030199042 Novel morphogenic protein
10/23/2003US20030199036 Ubiquitin ligases, and uses related thereto
10/23/2003US20030199033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199032 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199031 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199030 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199029 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199028 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199027 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030199026 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199025 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199023 A PRO polypeptide having a full-length amino acid sequence fused to heterologous polypeptide sequences
10/23/2003US20030199014 Addition of low levels of divalent metal ions or monovalent copper ion, together with calcium ions, enhance the anticoagulant activity of the Protein C anticoagulant patheway
10/23/2003US20030199013 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
10/23/2003US20030199012 A nucleic acid construct having a nucleic acid molecule that encodes a factor suppressing an immune response to Mycobacterium tuberculosis in a host cell
10/23/2003US20030199008 Nucleic Acids, Proteins, and antibodies
10/23/2003US20030199007 Are unique to diseased states, particularly tumors and blood-borne malignancies; useful for therapeutic purposes
10/23/2003US20030199006 Measurement of an intracellular metabolic marker in lymphocytes (such as ATP) as an indicator of a patient's immune response after receiving immnosuppressive drugs
10/23/2003US20030199005 Solid supports with minicells
10/23/2003US20030199004 Kits and methods useful in quantitatively measuring the amount of an analyte in a fluid sample by providing a solid phase apparatus comprising a membrane having an application point, a sample capture zone, and a control capture zone
10/23/2003US20030199003 High-level production of amyloid-beta peptides from IMR-32 cells
10/23/2003US20030199001 Filtering sample through a ultrafiltration device having a vertical ultrafilter membrane, recovery of filtrate, desalting using chromatography media, using MALDI/TOF target or HPLC column and mass spectrometry to analyze sample for biomarkers
10/23/2003US20030199000 Diagnostic markers of stroke and cerebral injury and methods of use thereof
10/23/2003US20030198999 Apparatus and method for synthesizing combinatorial libraries
10/23/2003US20030198998 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (MBL)
10/23/2003US20030198997 Determining, evaluating and analyzing the secondary and tertiary structures of macromolecule- ligand complexes and binding mechanisms through powder diffraction
10/23/2003US20030198996 Production of achromosomal and anucleate cells useful for diagnositic and therapeutic uses, as well as research tools and agents for drug discovery
10/23/2003US20030198995 Production of achromosomal and anucleate cells useful for diagnostic and therapeutic uses, as well as research tools and agents for drug discovery
10/23/2003US20030198994 Identification and isolation of novel DNA and the recombinant production of novel polypeptides encoded by that DNA
10/23/2003US20030198993 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2003US20030198992 Treatment or prophylaxis of diseases caused by pilus-forming bacteria
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198988 Optimization of crossover points for directed evolution
10/23/2003US20030198985 Assay for nitrous oxide neurologic syndrome
10/23/2003US20030198982 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
10/23/2003US20030198980 Heteroconfigurational polynucleotides and methods of use
10/23/2003US20030198979 Method for detecting hybridized nucleic acid with improved sensitivity
10/23/2003US20030198975 Proteins associated with cell growth, differentiation, and death
10/23/2003US20030198972 Grading of breast cancer
10/23/2003US20030198971 For producing a signal, phenotype, or other functional output in response to interaction of binding ensemble members; for use in vitro or in vivo
10/23/2003US20030198968 Coating a solid support via chemical plasma polymerization, and forming pendant functional group(s) for attaching a protein, nucleic acid or cell; polyacrylic acid with pendant acid groups converted to acyl fluorides for example
10/23/2003US20030198967 Multi-functional microarrays and methods
10/23/2003US20030198966 Displacement assay for detection of small molecules
10/23/2003US20030198964 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye
10/23/2003US20030198961 By measuring the level of a TIEG marker; used for therapy, diagnosis, prognosis
10/23/2003US20030198960 Signal amplifying targeted reporters for biological and chemical sensor applications
10/23/2003US20030198959 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/23/2003US20030198956 Staged assembly of nanostructures
10/23/2003US20030198954 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays
10/23/2003US20030198953 For diagnosis, treatment, and prevention of related disorders
10/23/2003US20030198952 Probe bound substrate, process for manufacturing same, probe array, method of detecting target substance, method of specifying nucleotide sequence of single-stranded nucleic acid in sample, and quantitative determination of target substance in sample
10/23/2003US20030198951 Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
10/23/2003US20030198949 Viral polypeptides that regulate or modulate apoptosis
10/23/2003US20030198947 Hepatitis virus sentinel virus I (SVI)
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198940 For rapid identification of protein molecules
10/23/2003US20030198939 In vitro culturing of monocytes in presence of monoclonal antibody
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198666 Side effect reduction; using mixture of insulin and adjuvant
10/23/2003US20030198664 Encapsulation drug; screening active materials
10/23/2003US20030198649 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
10/23/2003US20030198648 Determination binding; calibration
10/23/2003US20030198647 Rheumatic diseases; autoimmune disease
10/23/2003US20030198644 HCV peptide antigens and methods for the determination of HCV
10/23/2003US20030198636 Prevent completitive binding; amplification inflammation response; convertase inhibitor; side effect reduction
10/23/2003US20030198596 Genetic engineered plasmids; diagnosis glandular disorders
10/23/2003US20030198575 Method and the device for micro-particle array fabrication
10/23/2003US20030198574 Apparatus for handling biopsy specimens, and method for using it
10/23/2003US20030198272 Image read-out method and apparatus
10/23/2003US20030197852 Method for analyzing impurities in carbon dioxide
10/23/2003US20030197125 Apparatus and method for in situ, real time measurements of properties of liquids
10/23/2003US20030196894 Disposable sub-microliter volume biosensor with enhanced sample inlet
10/23/2003US20030196889 Cellulose nitrate membranes useful in immuno-assay diagnostic tests
10/23/2003US20030196498 Deep lysimeter
10/23/2003US20030196484 Method to quantify total raw coalbed desorbed gas volume from geophysical logs
10/23/2003US20030196479 System and method for determining oil quality
10/23/2003DE20311764U1 Test strip, for fluid samples, contains two circuits to make contact with the absorbed sample fluid, and transfer reaction signals to a measurement instrument for analysis when the strip is inserted
10/23/2003DE19932720C2 Verfahren zur Messung der Wirkung von Stoffen auf die Erregbarkeit zentralnervöser Zellen oder Zellverbände Method for measuring the effects of substances on the excitability of central nervous cells or cell clusters
10/23/2003CA2523385A1 System for quantifying blood flow in tissue with periodic updating of tissue baseline conditions
10/23/2003CA2521946A1 Method of identifying transmembrane protein-interacting compounds
1 ... 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 ... 3937